Quick Answer
HERON THERAPEUTICS, INC. /DE/ reported Total Assets of $255.88 million for the year ending 2025.
- HERON THERAPEUTICS, INC. /DE/ showed an increase of +9.7% in Total Assets from 2024 to 2025.
- This data is from HERON THERAPEUTICS, INC. /DE/'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $22.12 million | Q3 2011: $21.80 million | Q1 2012: $14.99 million | Q2 2012: $14.23 million | Q3 2012: $61.76 million | Q1 2013: $48.98 million | Q2 2013: $38.09 million | Q3 2013: $26.37 million | Q1 2014: $62.79 million | Q2 2014: $108.64 million | Q3 2014: $92.28 million | Q1 2015: $59.63 million | Q2 2015: $176.46 million | Q3 2015: $158.15 million | Q1 2016: $111.85 million | Q2 2016: $85.73 million | Q3 2016: $98.81 million | Q1 2017: $189.56 million | Q2 2017: $142.37 million | Q3 2017: $118.20 million | Q1 2018: $183.38 million | Q2 2018: $510.56 million | Q3 2018: $470.90 million | Q1 2019: $435.79 million | Q2 2019: $411.67 million | Q3 2019: $392.96 million | Q1 2020: $478.94 million | Q2 2020: $432.72 million | Q3 2020: $390.02 million | Q1 2021: $310.93 million | Q2 2021: $404.25 million | Q3 2021: $352.39 million | Q1 2022: $273.72 million | Q2 2022: $243.97 million | Q3 2022: $271.95 million | Q1 2023: $220.88 million | Q2 2023: $201.22 million | Q3 2023: $229.20 million | Q1 2024: $217.89 million | Q2 2024: $218.14 million | Q3 2024: $220.78 million | Q1 2025: $235.75 million | Q2 2025: $232.09 million | Q3 2025: $248.95 million.
- Over the full 16 years of available data (2010 to 2025), HERON THERAPEUTICS, INC. /DE/'s Total Assets has grown by 8,690.0%.
- Historical annual values: Fiscal year 2025: $255.88 million | Fiscal year 2024: $233.15 million | Fiscal year 2023: $222.51 million | Fiscal year 2022: $250.95 million | Fiscal year 2021: $305.71 million | Fiscal year 2020: $353.56 million | Fiscal year 2019: $512.78 million | Fiscal year 2018: $462.18 million | Fiscal year 2017: $234.31 million | Fiscal year 2016: $67.48 million | Fiscal year 2015: $137.85 million | Fiscal year 2014: $76.68 million | Fiscal year 2013: $75.94 million | Fiscal year 2012: $55.97 million | Fiscal year 2011: $19.45 million | Fiscal year 2010: $2.91 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: